145 related articles for article (PubMed ID: 23549874)
1. Molecular pathways: the complex roles of inflammation pathways in the development and treatment of liver cancer.
Nikolaou K; Sarris M; Talianidis I
Clin Cancer Res; 2013 Jun; 19(11):2810-6. PubMed ID: 23549874
[TBL] [Abstract][Full Text] [Related]
2. The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer.
Liedtke C; Trautwein C
Eur J Cell Biol; 2012; 91(6-7):582-9. PubMed ID: 22153863
[TBL] [Abstract][Full Text] [Related]
3. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis.
Bishayee A; Thoppil RJ; Darvesh AS; Ohanyan V; Meszaros JG; Bhatia D
J Nutr Biochem; 2013 Jan; 24(1):178-87. PubMed ID: 22841394
[TBL] [Abstract][Full Text] [Related]
4. Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer.
Friedbichler K; Themanns M; Mueller KM; Schlederer M; Kornfeld JW; Terracciano LM; Kozlov AV; Haindl S; Kenner L; Kolbe T; Mueller M; Snibson KJ; Heim MH; Moriggl R
Hepatology; 2012 Mar; 55(3):941-52. PubMed ID: 22031092
[TBL] [Abstract][Full Text] [Related]
5. The tumor microenvironment in hepatocellular carcinoma (review).
Leonardi GC; Candido S; Cervello M; Nicolosi D; Raiti F; Travali S; Spandidos DA; Libra M
Int J Oncol; 2012 Jun; 40(6):1733-47. PubMed ID: 22447316
[TBL] [Abstract][Full Text] [Related]
6. New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system.
Berasain C; Castillo J; Prieto J; Avila MA
Liver Int; 2007 Mar; 27(2):174-85. PubMed ID: 17311611
[TBL] [Abstract][Full Text] [Related]
7. The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy.
Sukowati CH; Tiribelli C
Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):749-57. PubMed ID: 24161136
[TBL] [Abstract][Full Text] [Related]
8. Latest developments in targeted therapy for hepatocellular carcinoma.
Montella L; Addeo R; Caraglia M; Del Prete S
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1635-46. PubMed ID: 20942634
[TBL] [Abstract][Full Text] [Related]
9. NF-κB and STAT3 - key players in liver inflammation and cancer.
He G; Karin M
Cell Res; 2011 Jan; 21(1):159-68. PubMed ID: 21187858
[TBL] [Abstract][Full Text] [Related]
10. Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.
Schattenberg JM; Schuchmann M; Galle PR
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():213-9. PubMed ID: 21199533
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of growth factor signaling in human hepatocellular carcinoma.
Breuhahn K; Longerich T; Schirmacher P
Oncogene; 2006 Jun; 25(27):3787-800. PubMed ID: 16799620
[TBL] [Abstract][Full Text] [Related]
12. TGF-β signaling in onset and progression of hepatocellular carcinoma.
Meindl-Beinker NM; Matsuzaki K; Dooley S
Dig Dis; 2012; 30(5):514-23. PubMed ID: 23108308
[TBL] [Abstract][Full Text] [Related]
13. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis.
Németh J; Stein I; Haag D; Riehl A; Longerich T; Horwitz E; Breuhahn K; Gebhardt C; Schirmacher P; Hahn M; Ben-Neriah Y; Pikarsky E; Angel P; Hess J
Hepatology; 2009 Oct; 50(4):1251-62. PubMed ID: 19670424
[TBL] [Abstract][Full Text] [Related]
14. Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.
Kudo M
Dig Dis; 2011; 29(3):273-7. PubMed ID: 21829017
[TBL] [Abstract][Full Text] [Related]
15. [Control of hepatocellular carcinoma progression by the tumor microenvironment].
Clement B
Bull Acad Natl Med; 2012 Jan; 196(1):75-84. PubMed ID: 23259335
[TBL] [Abstract][Full Text] [Related]
16. Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma.
Gong K; Li W
Free Radic Biol Med; 2011 Dec; 51(12):2259-71. PubMed ID: 22011623
[TBL] [Abstract][Full Text] [Related]
17. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
Frau M; Biasi F; Feo F; Pascale RM
Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
[TBL] [Abstract][Full Text] [Related]
18. Pathways and gene expression profiles in hepatocellular carcinoma.
Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Giorgio F; Del Prete V; Panella C; Ierardi E
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):35-48. PubMed ID: 22419003
[TBL] [Abstract][Full Text] [Related]
19. Role and significance of focal adhesion proteins in hepatocellular carcinoma.
Yam JW; Tse EY; Ng IO
J Gastroenterol Hepatol; 2009 Apr; 24(4):520-30. PubMed ID: 19368632
[TBL] [Abstract][Full Text] [Related]
20. Molecular targeted therapy in hepatocellular carcinoma: present achievements and future challenges.
Giacomin A; Sergio A; Vanin V; Gazzola A; Cazzagon N; Farinati F
Dig Dis; 2012; 30(3):284-8. PubMed ID: 22722553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
